Phillip Dan Cook - Carlsbad CA, US Yogesh Shantilal Sanghvi - San Marcos CA, US Jean Jacques Vasseur - Carlsbad CA, US Francoise Debart - Carlsbad CA, US
Therapeutic oligonucleotide analogues which have improved nuclease resistance and improved cellular uptake are provided. Replacement of the normal phosphorodiester inter-sugar linkages found in natural oligomers with four atom linking groups forms unique di- and poly-nucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.
Phillip Dan Cook - Carlsbad CA Yogesh Shantilal Sanghvi - San Marcos CA Jean Jacques Vasseur - Carlsbad CA Francoise Debart - Carlsbad CA
Assignee:
Isis Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
C07H 2100
US Classification:
536 231
Abstract:
Therapeutic oligonucleotide analogues which have improved nuclease resistance and improved cellular uptake are provided. Replacement of the normal phosphorodiester inter-sugar linkages found in natural oligomers with four atom linking groups forms unique di- and poly-nucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.